Obstet Gynecol Sci.
2022 Jan;65(1):103-104. 10.5468/ogs.21273.
Comment on: hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
- Affiliations
-
- 1Department of Obstetrics and Gynecology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
- KMID: 2524691
- DOI: http://doi.org/10.5468/ogs.21273
Reference
-
Reference
1. Ko J, Ha HI, Choi MC, Jung SG, Park H, Joo WD, et al. Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer. Obstet Gynecol Sci. 2021; 64:437–43.
Article
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Chemotherapy for ovarian cancer
- Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
- Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
- Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study
- Advanced ovarian cancer: what should be the standard of care?
